Amazon.com Inc. (NASDAQ:AMZN) Reached the 52-Week High of $85.85
Amazon.com Inc. seeks to be the world's most customer-centric company where customers can find and discover anything they may want to buy online. The company lists unique items in categories such as books, music, DVDs, videos, consumer electronics, toys, and more. Amazon.com Inc. has a market cap of $36.89 billion; its shares were traded at around $85.85 with a P/E ratio of 54.7 and P/S ratio of 1.9.
On April 23, 2009, Amazon.com Inc. reported results for the first quarter of 2009. Net sales increased 18% to $4.89 billion in the first quarter, compared with $4.13 billion in first quarter 2008. Net income increased 24% to $177 million in the first quarter, compared with net income of $143 million in first quarter 2008.
Amazon.com Inc. is in the portfolios of Bill Miller of Legg Mason Value Trust, Bill Miller of Legg Mason Value Trust, John Griffin of Blue Ridge Capital, Ken Heebner of CAPITAL GROWTH MANAGEMENT LP, John Hussman of Hussman Economtrics Advisors, Inc., Chris Davis of Davis Selected Advisers, PRIMECAP Management, and Ron Baron of Baron Funds.
In May, Sell: Chairman, CEO and President, 10% Owner Jeffrey P Bezos sold 1,000,000 shares of AMZN stock; the price of the stock has increased by 8.59% since. Several other officers sold shares in June.
Wipro Ltd. (NYSE:WIT) Reached the 52-Week High of $13.06
Wipro Ltd. provides comprehensive IT solutions and services including systems integration, outsourcing, package implementation, software application, development, and maintenance, and research and development services to corporations globally. Wipro Ltd. has a market cap of $19.13 billion; its shares were traded at around $13.06 with a P/E ratio of 24.2 and P/S ratio of 3.8. The dividend yield of Wipro Ltd. stocks is 0.6%. Wipro Ltd. had an annual average earning growth of 31.9% over the past 5 years.
Wipro Ltd will announce financial results for the quarter ended June 30, 2009 on Wednesday, July 22.
Quest Diagnostics Inc. (NYSE:DGX) Reached the 52-Week High of $55.88
Quest Diagnostics Inc. is the leading provider of diagnostic testing information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers. Quest Diagnostics Inc. has a market cap of $10.36 billion; its shares were traded at around $55.88 with a P/E ratio of 16 and P/S ratio of 1.4. The dividend yield of Quest Diagnostics Inc. stocks is 0.7%. Quest Diagnostics Inc. had an annual average earning growth of 23.9% over the past 10 years. GuruFocus rated Quest Diagnostics Inc. the business predictability rank of 4-star.
On July 9, Quest Diagnostics Inc. reported that its results for the second quarter of 2009 will be released on July 21.
Quest Diagnostics Inc. is in the portfolios of Edward Owens of Vanguard Health Care Fund, Robert Olstein of Olstein Financial Alert Fund, and John Hussman of Hussman Economtrics Advisors, Inc.
In February, Sell: Chairman, President & CEO, Director Surya N Mohapatra sold 10,884 shares of DGX stock and the price of the stock increased by 12.32%. Many other officers have sold shares in February and March.
Bed Bath & Beyond Inc. (NASDAQ:BBBY) Reached the 52-Week High of $32.65
Bed Bath & Beyond is a nationwide operator of superstores selling domestics merchandise and home furnishings typically found in department stores. The company's domestics merchandise line includes items such as bed linens, bath accessories, and kitchen textiles. Bed Bath & Beyond Inc. has a market cap of $8.52 billion; its shares were traded at around $32.65 with a P/E ratio of 19.3 and P/S ratio of 1.1. Bed Bath & Beyond Inc. had an annual average earning growth of 24.1% over the past 10 years. GuruFocus rated Bed Bath & Beyond Inc. [url= http://www.gurufocus.com/predictable.php]the business predictability rank of 4-star[/url].
On June 24, Bed Bath & Beyond Inc. reported net earnings of $.34 per diluted share in the fiscal first quarter ended May 30, 2009, compared with net earnings of $.30 per diluted share in the same quarter a year ago. Net sales for the fiscal first quarter of 2009 were approximately $1.694 billion, an increase of approximately 2.8% from net sales of $1.648 billion reported in the fiscal first quarter of 2008.
Bed Bath & Beyond Inc. is in the portfolios of Chris Davis of Davis Selected Advisers, Brian Rogers of T Rowe Price Equity Income Fund, PRIMECAP Management, Arnold Van Den Berg of Century Management, Wallace Weitz of Weitz Wallace R & Co, Richard Aster Jr of Meridian Fund, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, and Richard Pzena of Pzena Investment Management LLC.
In April, Sell: CEO Steven H Temares sold 400,000 shares of BBBY stock. The price of the stock has increased by 5.19%. Sell: CFO and Treasurer Eugene A Castagna sold 30,000 shares the same month. In June, Sell: President and CMO Arthur Stark sold 57,700 shares.